Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5841439 | 1.00 | TDP1 (0.50) | TDP1L3MBTL1 | |
| SCHEMBL29373976 | 1.00 | TDP1 (0.50) | TDP1L3MBTL1 | |
| SCHEMBL586406 | 1.00 | TDP1 (0.50) | TDP1L3MBTL1 | |
| SCHEMBL17019828 | 0.99 | — | — | |
| SCHEMBL2815497 | 0.94 | TSHR (0.51) | — | |
| SCHEMBL1566425 | 0.94 | BCHE (0.45) | TDP1L3MBTL1 | |
| SCHEMBL17577593 | 0.92 | — | — | |
| SCHEMBL2578105 | 0.88 | GLS (0.46) | — | |
| SCHEMBL13771640 | 0.87 | TDP1 (0.49) | TDP1L3MBTL1 | |
| SCHEMBL7329451 | 0.86 | TDP1 (0.48) | TDP1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9861557-B2 | Dental materials on the basis of urea group-containing monomers | IVOCLAR VIVADENT AG (LI) | 2018-01-09 | — | — | US | disclosed |
| US-9861557-B2 | Dental materials on the basis of urea group-containing monomers | IVOCLAR VIVADENT AG (LI) | 2018-01-09 | — | — | US | disclosed |
| EP-2823801-B1 | Dental materials on the basis of monomers containing urea groups | IVOCLAR VIVADENT AG (LI) | 2017-04-19 | — | — | EP | disclosed |
| EP-2823801-B1 | Dental materials on the basis of monomers containing urea groups | IVOCLAR VIVADENT AG (LI) | 2017-04-19 | — | — | EP | disclosed |
| US-20160151249-A1 | DENTAL MATERIALS ON THE BASIS OF UREA GROUP-CONTAINING MONOMERS | IVOCLAR VIVADENT AG (LI) | 2016-06-02 | — | — | US | disclosed |
| US-20160151249-A1 | DENTAL MATERIALS ON THE BASIS OF UREA GROUP-CONTAINING MONOMERS | IVOCLAR VIVADENT AG (LI) | 2016-06-02 | — | — | US | disclosed |
| US-20160151249-A1 | DENTAL MATERIALS ON THE BASIS OF UREA GROUP-CONTAINING MONOMERS | IVOCLAR VIVADENT AG (LI) | 2016-06-02 | — | — | US | disclosed |
| WO-2015003812-A1 | DENTAL MATERIALS ON THE BASIS OF UREA GROUP-CONTAINING MONOMERS | IVOCLAR VIVADENT AG (LI) | 2015-01-15 | — | — | WO | disclosed |
| EP-2823801-A1 | Dental materials on the basis of monomers containing urea groups | Ivoclar Vivadent AG (LI) | 2015-01-14 | — | — | EP | disclosed |
| WO-2009086835-A1 | NOVEL CYANOGUANIDINES | TOPOTARGET A/S (DK) | 2009-07-16 | — | — | WO | disclosed |
| WO-2009086835-A1 | NOVEL CYANOGUANIDINES | TOPOTARGET A/S (DK) | 2009-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160151249-A1 | DENTAL MATERIALS ON THE BASIS OF UREA GROUP-CONTAINING MONOMERS | UFM1, SLC14A1, USO1 | TDP1 2345/4885L3MBTL1 1947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.